Platelet mitochondrial respiratory chain function in Parkinson's disease

Movement Disorders

Volumn 12, Issue 1, 1997, Pages 3-8

  Blake, C I ^a   Spitz, E ^a   Leehey, M ^a   Hoffer, B J ^a,b   Boyson, S J ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Blood platelets; Citrate synthase; Complex I; Complex III; Complex IV; Cytochrome c oxidase; Cytochrome c reductase; NADH dehydrogenase; Parkinson's disease; Ubiquinol; Ubiquinone

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; MALE; MITOCHONDRIAL RESPIRATION; NEUROPATHOLOGY; NORMAL HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATORY CHAIN; RISK FACTOR; SPECTROPHOTOMETRY; SUBSTANTIA NIGRA; THROMBOCYTE;

ADULT; AGED; BLOOD PLATELETS; CITRATE (SI)-SYNTHASE; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX III; ELECTRON TRANSPORT COMPLEX IV; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; NAD(P)H DEHYDROGENASE (QUINONE); PARKINSON DISEASE; REFERENCE VALUES;

EID: 0031031845     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120103     Document Type: Article

References (12)

1. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex deficiency in Parkinson's disease. Lancet 1989;1:1269.
2. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992;115:333-42.
3. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-7.
4. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-5.
5. Janetzky B, Hauck S, Youdim MBH, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994;169:126-8.
6. Leehey M, Boyson SJ. The biochemistry of Parkinson's disease. In: Appel SH, ed. Current neurology, vol 11. St. Louis: Mosby Year Book, 1991:233-86.
7. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neural 1992;32:804-12.
8. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-95.
9. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neural 1989;26:719-23.
10. Bravi D, Anderson JJ, Dagani F, et al. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord 1992;7:228-31.
11. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AHV. Platelet mitochondrial function in Parkinson's disease. Ann Neural 1992;32:782-8.
12. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm 1992;4:27-34.